Literature DB >> 14713061

Assessing conformance to medication treatment guidelines for schizophrenia in a community mental health center (CMHC).

Mona Goldman1, Daniel J Healy, Timothy Florence, Lorelei Simpson, Karen K Milner.   

Abstract

The feasibility of implementing current medication treatment guidelines in a community mental health clinic was examined in this cross-sectional and retrospective study. Specifically, two issues were addressed: 1) could we identify a set of clinical guidelines whose utilization could be monitored with a routine medical chart review; and 2) were the requisite data for such a review available in the medical records. An examination of three sets of published guidelines revealed 5 specific guidelines that could be operationalized and monitored. Records were reviewed for a random sample of two-thirds of all patients currently diagnosed with schizophrenia and schizoaffective disorder (n = 309). Information was collected from the medical record on patient demographics, diagnosis, duration of illness, symptoms and side effects, and medication information. Rates of conformance to the 5 guidelines ranged from a high of 97% to a low of 43%. The use of current guidelines to improve treatment in community clinics appears to be limited by the deficiencies in the medical record and the structure of the guidelines themselves. Standardized progress notes and computerized prescribing programs will improve conformance, and permit the rapid and accurate assessment of conformance to guidelines in community clinics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14713061     DOI: 10.1023/b:comh.0000003015.68850.f2

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  12 in total

1.  Treatment of schizophrenia 1999. The expert consensus guideline series.

Authors: 
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

2.  Cost of treating mental illness from a managed care perspective.

Authors:  J P Docherty
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

3.  Implementing best-practice guidelines for schizophrenia in a public-sector institution.

Authors:  A M Dassori; J A Chiles; E Swenson-Britt
Journal:  Psychiatr Serv       Date:  2000-08       Impact factor: 3.084

4.  Using a computer database to monitor compliance with pharmacotherapeutic guidelines for schizophrenia.

Authors:  R S Chen; P M Nadkarni; F L Levin; P L Miller; J Erdos; R A Rosenheck
Journal:  Psychiatr Serv       Date:  2000-06       Impact factor: 3.084

5.  Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association.

Authors: 
Journal:  Am J Psychiatry       Date:  1997-04       Impact factor: 18.112

6.  The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm.

Authors:  J A Chiles; A L Miller; M L Crismon; A J Rush; A S Krasnoff; S S Shon
Journal:  Psychiatr Serv       Date:  1999-01       Impact factor: 3.084

7.  Antipsychotic dosing patterns for schizophrenia in three treatment settings.

Authors:  G Remington; C M Shammi; R Sethna; R Lawrence
Journal:  Psychiatr Serv       Date:  2001-01       Impact factor: 3.084

8.  Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

Authors:  A F Lehman; D M Steinwachs
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

Review 9.  New atypical antipsychotic medications.

Authors:  M D Jibson; R Tandon
Journal:  J Psychiatr Res       Date:  1998 May-Aug       Impact factor: 4.791

10.  Measuring the quality of outpatient treatment for schizophrenia.

Authors:  A S Young; G Sullivan; M A Burnam; R H Brook
Journal:  Arch Gen Psychiatry       Date:  1998-07
View more
  5 in total

1.  A conditional model of evidence-based decision making.

Authors:  Paul R Falzer; Melissa D Garman
Journal:  J Eval Clin Pract       Date:  2009-12       Impact factor: 2.431

2.  Unmet need for mental health care in schizophrenia: an overview of literature and new data from a first-admission study.

Authors:  Ramin Mojtabai; Laura Fochtmann; Su-Wei Chang; Roman Kotov; Thomas J Craig; Evelyn Bromet
Journal:  Schizophr Bull       Date:  2009-06-08       Impact factor: 9.306

3.  Community adherence to schizophrenia treatment and safety monitoring guidelines.

Authors:  William R Keller; Bernard A Fischer; Robert McMahon; Walter Meyer; Melissa Blake; Robert W Buchanan
Journal:  J Nerv Ment Dis       Date:  2014-01       Impact factor: 2.254

4.  Evaluation of a treatment manual for risperidone long-acting injectable.

Authors:  John P Docherty; Robert Jones; Ibrahim Turkoz; Robert A Lasser; Mary Kujawa
Journal:  Community Ment Health J       Date:  2007-03-08

5.  Incorporating clinical guidelines through clinician decision-making.

Authors:  Paul R Falzer; Brent A Moore; D Melissa Garman
Journal:  Implement Sci       Date:  2008-02-29       Impact factor: 7.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.